在体外和体外均可激活N-氧化物和西利博的生物直角分解化学
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。研究人员使用N-氧化物和西利博开发了一种新型的生物对应性腐蚀化学物质. 这一突破为化学生物学和药物输送的潜在应用提供了快速高效的有效释放.
科学领域
- 生物对角化学
- 有机化学
- 化学生物学
背景情况
- 在体内应用中,生物直角分解化学是至关重要的,但目前缺乏速度和效率.
- 现有的方法往往具有缓慢的动力和有限的效率,阻碍了它们的治疗潜力.
研究的目的
- 开发一种新的,高效的,快速的生物对应性分解化学系统.
- 创建一个N-氧化物掩盖的自焚间隔器,
- 评估使用这种新化学物质的纳米原药的体内疗效.
主要方法
- 研究了N-氧化物和西尔之间的反应动力学,将其与传统的酸系统进行比较.
- 设计和合成一个N-氧化物掩盖的自焚间隔器,用于控制药物释放.
- 在4T1小鼠乳腺瘤模型中开发并测试了一种基于N-氧化物的自组合生物对角纳米前药物.
主要成果
- 在N-氧化物衰减动力学中实现了10^6倍的加速 (k2高达10^3 M^-1 s^-1).
- 使用新型的N-氧化物掩盖间隔器,证明了高效率 (> 90%) 的无痕释放有效载荷.
- 与原始药物相比,使用纳米原药治疗的小鼠显著增强瘤抑制.
结论
- 引入了基于N-氧化物和西利的新生物直角点击释放化学反应,
- 开发的系统对推进化学生物学工具和药物输送策略有很大的前景.
- 预计这种化学物质在需要精确的分子控制的生物系统中具有广泛的应用.
相关概念视频
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...